These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 10757341)

  • 1. Problems in the differential diagnosis of endometrial hyperplasia and carcinoma.
    Silverberg SG
    Mod Pathol; 2000 Mar; 13(3):309-27. PubMed ID: 10757341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unusual epithelial and stromal changes in myoinvasive endometrioid adenocarcinoma: a study of their frequency, associated diagnostic problems, and prognostic significance.
    Murray SK; Young RH; Scully RE
    Int J Gynecol Pathol; 2003 Oct; 22(4):324-33. PubMed ID: 14501811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD10 immunostaining distinguishes atypical polypoid adenomyofibroma (atypical polypoid adenomyoma) from endometrial carcinoma invading the myometrium.
    Ohishi Y; Kaku T; Kobayashi H; Aishima S; Umekita Y; Wake N; Tsuneyoshi M
    Hum Pathol; 2008 Oct; 39(10):1446-53. PubMed ID: 18619643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of glucose transporter-1 in endometrial hyperplasia and well-differentiated endometrioid adenocarcinoma].
    Liu AJ; Hou N; Chen LZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Aug; 23(4):398-400. PubMed ID: 12940086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Papillary proliferation of the endometrium: a clinicopathologic study of 59 cases of simple and complex papillae without cytologic atypia.
    Ip PP; Irving JA; McCluggage WG; Clement PB; Young RH
    Am J Surg Pathol; 2013 Feb; 37(2):167-77. PubMed ID: 23211295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determining the inter- and intraobserver reproducibility of the diagnosis of endometrial hyperplasia subgroups and well-differentiated endometrioid carcinoma in endometrial curettage specimens.
    Izadi-Mood N; Khaniki M; Irvanloo G; Ahmadi SA; Hayeri H; Meysamie A
    Arch Iran Med; 2009 Jul; 12(4):377-82. PubMed ID: 19566355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperplasia and carcinoma in secretory endometrium: a diagnostic challenge.
    Truskinovsky AM; Lifschitz-Mercer B; Czernobilsky B
    Int J Gynecol Pathol; 2014 Mar; 33(2):107-13. PubMed ID: 24487463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Histologic diagnosis of endometrial cancer].
    Kaku T; Kawano Y; Hagiwara T
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():309-12. PubMed ID: 15535257
    [No Abstract]   [Full Text] [Related]  

  • 9. New aspects of endometrial carcinoma.
    Silverberg SG
    Clin Obstet Gynaecol; 1984 Apr; 11(1):189-208. PubMed ID: 6370532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-grade endometrial adenocarcinoma: a diagnostic algorithm for distinguishing atypical endometrial hyperplasia and other benign (and malignant) mimics.
    McKenney JK; Longacre TA
    Adv Anat Pathol; 2009 Jan; 16(1):1-22. PubMed ID: 19098463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
    Wheeler DT; Bristow RE; Kurman RJ
    Am J Surg Pathol; 2007 Jul; 31(7):988-98. PubMed ID: 17592264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microglandular adenocarcinoma of the endometrium: a form of mucinous adenocarcinoma that may be confused with microglandular hyperplasia of the cervix.
    Zaloudek C; Hayashi GM; Ryan IP; Powell CB; Miller TR
    Int J Gynecol Pathol; 1997 Jan; 16(1):52-9. PubMed ID: 8986533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical stromal involvement by endometrial 'hyperplasia': a previously unreported phenomenon with recommendations to report as stage II endometrial carcinoma.
    Taylor J; McCluggage WG
    Pathology; 2021 Aug; 53(5):568-573. PubMed ID: 34154843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Endometrial hyperplasias: histology, classification, prognostic significance and therapy].
    Horn LC; Bilek K; Schnurrbusch U
    Zentralbl Gynakol; 1997; 119(6):251-9. PubMed ID: 9312959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hormone receptors and markers in endometrial hyperplasia. Immunohistochemical study].
    Pungal A; Balan R; Cotuţiu C
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(1):180-4. PubMed ID: 20509298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Glut-1 in Normal Endometrium and Endometrial Lesions: Analysis of 336 Cases.
    Němejcová K; Rosmusová J; Bártů M; Důra M; Tichá I; Dundr P
    Int J Surg Pathol; 2017 Aug; 25(5):389-396. PubMed ID: 28381136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathology of endometrial hyperplasia and endometrial carcinoma: an update.
    Horn LC; Meinel A; Handzel R; Einenkel J
    Ann Diagn Pathol; 2007 Aug; 11(4):297-311. PubMed ID: 17630117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Claudin 1 differentiates endometrioid and serous papillary endometrial adenocarcinoma.
    Sobel G; Németh J; Kiss A; Lotz G; Szabó I; Udvarhelyi N; Schaff Z; Páska C
    Gynecol Oncol; 2006 Nov; 103(2):591-8. PubMed ID: 16797678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Difficulties in assessing the depth of myometrial invasion in endometrial carcinoma.
    Ali A; Black D; Soslow RA
    Int J Gynecol Pathol; 2007 Apr; 26(2):115-23. PubMed ID: 17413976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and prognostic significance of urokinase and plasminogen activator inhibitor type-1 in endometrial hyperplasia and cancer.
    Taponeco F; Curcio C; Giuntini A; Nardini V; Fornaciari G; Artini PG; D'Ambrogio G; Genazzani AR
    J Exp Clin Cancer Res; 2001 Jun; 20(2):239-46. PubMed ID: 11484981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.